Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-59.40	178.27	439.10
Graham Fair Price	76.34	4.52	2.56
PEG	-88.54	0.32	-2.75
Price/Book	-15.93	2.00	2.38
Price/Cash Flow	263.44	-96.30	26.50
Prices/Earnings	-72.55	65.84	239.87
Price/Sales	80.93	30.52	16.87
Price/FCF	263.44	-96.30	26.50
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	61.71	0.31	0.19
Operating Margin	1602.47	0.14	< 0.005
ROA	214.78	< 0.005	< 0.005
ROE	< 0.005	< 0.005	206.26
ROIC	< 0.005	< 0.005	374.89
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.40	2.00	-80.21
Dividends QOQ	-0.71	-0.42	40.89
EBIT QOQ	-0.95	6.97	636.68
EPS QOQ	-0.87	2.09	139.62
FCF QOQ	1.03	-1.23	20.06
Revenue QOQ	-0.23	-0.53	-129.05
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	175.85	530.46	201.66
Days Sales Outstanding (DSO)	230.49	441.15	91.39
Inventory Turnover	0.51	0.17	-66.85
Debt/Capitalization	0.19	0.12	-35.24
Quick Ratio	1.87	1.70	-8.65
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	10.84	10.92	0.76
Cash	4.65	3.64	-21.61
Capex	-0.08	-0.09	-10.67
Free Cash Flow	0.97	-0.23	-76.69
Revenue	1.53	0.72	-53.18
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.49	2.62	5.14
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-10.49	-19.31	-84.15
Naive Interpretation	Member

06 - Financial Health · Bad

Rating